<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.marketkrystal.com/wp-content/plugins/rss-feed-styles/public/template.xsl"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:rssFeedStyles="http://www.lerougeliet.com/ns/rssFeedStyles#"
>

<channel>
	<title>FMC Archives | Market Krystal</title>
	<atom:link href="https://www.marketkrystal.com/chemical-news/company/fmc/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.marketkrystal.com/chemical-news/company/fmc/</link>
	<description>Voice of Chemical Industry Leaders</description>
	<lastBuildDate>Wed, 28 Oct 2026 05:38:24 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.7</generator>
<rssFeedStyles:reader name="Digg Reader" url="http://digg.com/reader/search/https%3A%2F%2Fwww.marketkrystal.com%2Ffeed%2F"/><rssFeedStyles:reader name="Feedly" url="http://cloud.feedly.com/#subscription%2Ffeed%2Fhttps://www.marketkrystal.com/feed/"/><rssFeedStyles:reader name="Inoreader" url="http://www.inoreader.com/?add_feed=https%3A%2F%2Fwww.marketkrystal.com%2Ffeed%2F"/><rssFeedStyles:button name="Like" url="https://www.facebook.com/sharer/sharer.php?u=%url%"/><rssFeedStyles:button name="G+" url="https://plus.google.com/share?url=%url%"/><rssFeedStyles:button name="Tweet" url="https://twitter.com/intent/tweet?url=%url%"/><site xmlns="com-wordpress:feed-additions:1">148046184</site>	<item>
		<title>FMC and Corteva sign rimisoxafen herbicide supply and license agreement</title>
		<link>https://www.marketkrystal.com/chemical-news/fmc-and-corteva-sign-rimisoxafen-herbicide-supply-and-license-agreement/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate>
				<guid isPermaLink="false">https://www.marketkrystal.com/chemical-news/fmc-and-corteva-sign-rimisoxafen-herbicide-supply-and-license-agreement/</guid>

					<description><![CDATA[<p>FMC Corporation and Corteva signed a co-exclusive strategic supply and license agreement covering FMC's rimisoxafen herbicide technology across North and South American corn and soybean markets, running through the next…</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-and-corteva-sign-rimisoxafen-herbicide-supply-and-license-agreement/">FMC and Corteva sign rimisoxafen herbicide supply and license agreement</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="mkn-brief">FMC Corporation and Corteva signed a co-exclusive strategic supply and license agreement covering FMC&#039;s rimisoxafen herbicide technology across North and South American corn and soybean markets, running through the next decade. FMC retains ownership of rimisoxafen and will supply the active ingredient to Corteva, while both companies develop and commercialize their own exclusive premix formulations. Corteva will make an initial prepurchase payment of $200 million USD, and first commercial sales are anticipated by the end of the decade, pending regulatory approvals.</p>
<div class="mkn-why"><strong>Why it matters</strong></p>
<p>Corteva&#039;s $200 million prepurchase and supply role give FMC a committed outlet for rimisoxafen active ingredient, while Corteva adds a dual mode of action tool against resistant Amaranthus and waterhemp in the Americas.</p>
</div>
<h2>Key facts</h2>
<table class="mkn-facts">
<tbody>
<tr>
<th scope="row">Companies</th>
<td>FMC Corporation, Corteva, Inc.</td>
</tr>
<tr>
<th scope="row">Chemicals</th>
<td>rimisoxafen</td>
</tr>
<tr>
<th scope="row">Investment</th>
<td>Initial prepurchase payment of $200 million USD from Corteva for product to be supplied by FMC</td>
</tr>
<tr>
<th scope="row">Timing</th>
<td>June 16, 2026, First commercial sales anticipated by the end of the decade, pending regulatory approvals, Agreement extends through the next decade</td>
</tr>
<tr>
<th scope="row">Partners</th>
<td>Corteva, Inc.</td>
</tr>
<tr>
<th scope="row">End uses</th>
<td>Corn and soybean growers in North and South America, Weed control in corn and soybeans, including Amaranthus species, palmer amaranth and waterhemp</td>
</tr>
</tbody>
</table>
<h2>Market context</h2>
<p>Herbicides are chemicals used to control unwanted plants, and they are a major input for field crops. Corn and soybeans are the largest end markets for herbicide active ingredients in the Americas, where growers depend on effective chemistry to manage weeds. Demand is shaped by weed resistance, since growers need tools with different modes of action to rotate in and out of their programs. Herbicide active ingredients are typically manufactured by a small number of producers and then formulated into premixes or sold as standalone products by different companies. Arrangements that split supply from formulation can give the active-ingredient producer committed volume and a steady revenue base, while giving partners access to new chemistry without building their own manufacturing. Such deals can also influence competitive dynamics in weed control, as they add options to a market where resistance management is a constant concern.</p>
<p class="mkn-source">Source: <a href="https://www.fmc.com/en/articles/fmc-corporation-and-corteva-expand-access-breakthrough-rimisoxafen-herbicide-technology" target="_blank" rel="noopener nofollow">official release on fmc.com</a>. Summary and context written by Market Krystal.</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-and-corteva-sign-rimisoxafen-herbicide-supply-and-license-agreement/">FMC and Corteva sign rimisoxafen herbicide supply and license agreement</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2543</post-id>	</item>
		<item>
		<title>FMC Corporation Cuts Prices and Resets US Pricing Model Amid Weak Quarter</title>
		<link>https://www.marketkrystal.com/chemical-news/fmc-corporation-cuts-prices-and-resets-us-pricing-model-amid-weak-quarter/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate>
				<guid isPermaLink="false">https://www.marketkrystal.com/chemical-news/fmc-corporation-cuts-prices-and-resets-us-pricing-model-amid-weak-quarter/</guid>

					<description><![CDATA[<p>FMC Corporation now expects third-quarter 2026 revenue of $65 million to $125 million and Adjusted EBITDA of negative $565 million to negative $510 million, including an estimated $625 million to…</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-corporation-cuts-prices-and-resets-us-pricing-model-amid-weak-quarter/">FMC Corporation Cuts Prices and Resets US Pricing Model Amid Weak Quarter</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="mkn-brief">FMC Corporation now expects third-quarter 2026 revenue of $65 million to $125 million and Adjusted EBITDA of negative $565 million to negative $510 million, including an estimated $625 million to $675 million impact from commercial actions. The company is lowering prices on select products held by channel customers in Brazil, Argentina, the United States and Canada, and is shifting its United States model from high gross-price, high-rebate sales toward a narrower gap between gross and net pricing. FMC will report third-quarter earnings on October 29, 2026, and share preliminary 2027 and 2028 expectations on October 30, 2026.</p>
<h2>Key facts</h2>
<table class="mkn-facts">
<tbody>
<tr>
<th scope="row">Companies</th>
<td>FMC Corporation, Tessenderlo Group</td>
</tr>
<tr>
<th scope="row">Chemicals</th>
<td>rimisoxafen</td>
</tr>
<tr>
<th scope="row">Investment</th>
<td>Approximately $625 million to $675 million impact related to commercial actions on revenue and Adjusted EBITDA</td>
</tr>
<tr>
<th scope="row">Timing</th>
<td>October 15, 2026, September 30, 2026, October 29, 2026, October 30, 2026</td>
</tr>
<tr>
<th scope="row">Partners</th>
<td>Channel customers and distributors, Bank group</td>
</tr>
<tr>
<th scope="row">End uses</th>
<td>Growers, Corn and soybean crops in Brazil</td>
</tr>
</tbody>
</table>
<h2>Market context</h2>
<p>Crop protection chemicals such as herbicides, insecticides and fungicides protect corn, soybean, cotton, fruit and vegetable crops from pests, weeds and disease, and demand for them tracks farm incomes, planting areas and weather. Large markets include Brazil, Argentina, the United States and Canada, where grower purchases are heavily shaped by distributor inventories and seasonal buying windows. When a major agrochemical supplier lowers prices on products held by channel customers, it can clear excess inventory and pull prices lower across the category, while generics makers and rival brands may need to respond. Shifting from high list prices and large rebates toward a narrower gap between gross and net prices changes how margins are reported and how distributors plan purchases. Buyers often read such moves as a sign of softer demand or competitive pressure, and investors watch them closely for effects on sales volumes and profitability across the sector.</p>
<p class="mkn-source">Source: <a href="https://www.fmc.com/en/articles/fmc-corporation-provides-update-third-quarter-expectations-and-announces-comprehensive" target="_blank" rel="noopener nofollow">official release on fmc.com</a>. Summary and context written by Market Krystal.</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-corporation-cuts-prices-and-resets-us-pricing-model-amid-weak-quarter/">FMC Corporation Cuts Prices and Resets US Pricing Model Amid Weak Quarter</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2542</post-id>	</item>
		<item>
		<title>FMC Corporation Welcomes Tessenderlo Group as 20% Minority Shareholder</title>
		<link>https://www.marketkrystal.com/chemical-news/fmc-corporation-welcomes-tessenderlo-group-as-20-minority-shareholder/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate>
				<guid isPermaLink="false">https://www.marketkrystal.com/chemical-news/fmc-corporation-welcomes-tessenderlo-group-as-20-minority-shareholder/</guid>

					<description><![CDATA[<p>Tessenderlo Group has completed a minority equity investment in FMC Corporation, buying 30,319,166 common shares at $13.30 each for an aggregate purchase price of about $403 million. The stake gives…</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-corporation-welcomes-tessenderlo-group-as-20-minority-shareholder/">FMC Corporation Welcomes Tessenderlo Group as 20% Minority Shareholder</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="mkn-brief">Tessenderlo Group has completed a minority equity investment in FMC Corporation, buying 30,319,166 common shares at $13.30 each for an aggregate purchase price of about $403 million. The stake gives Tessenderlo approximately 20.0% of FMC&#039;s outstanding common stock, the right to nominate one independent director, and it has nominated Luc Tack, its chief executive officer. Tessenderlo has agreed to customary standstill restrictions and a three-year lock-up period. The definitive agreement was signed on June 30, 2026.</p>
<h2>Key facts</h2>
<table class="mkn-facts">
<tbody>
<tr>
<th scope="row">Companies</th>
<td>FMC Corporation, Tessenderlo Group</td>
</tr>
<tr>
<th scope="row">Investment</th>
<td>Aggregate purchase price of approximately $403 million for 30,319,166 FMC common shares at $13.30 per share</td>
</tr>
<tr>
<th scope="row">Timing</th>
<td>June 30, 2026 (definitive agreement), September 23, 2026 (closing announcement)</td>
</tr>
<tr>
<th scope="row">Partners</th>
<td>Tessenderlo Group, FMC Corporation</td>
</tr>
<tr>
<th scope="row">End uses</th>
<td>Agricultural sciences, Crop protection</td>
</tr>
</tbody>
</table>
<h2>Market context</h2>
<p>FMC is a crop protection company, and its products, including herbicides, insecticides and fungicides, help growers control weeds, insects and plant diseases that reduce yields. Demand for these products tracks farm incomes, planted acreage, crop prices and pest pressure, so agricultural cycles drive much of the sector&#039;s volume and pricing. Crop protection chemistry is capital intensive and heavily regulated, which makes large shareholder positions and governance changes significant for companies in the space. Investors often watch such stakes for signs of strategic direction, while buyers watch for any effect on product availability, contract terms or pricing. Minority stakes of this size typically do not change day-to-day operations on their own, but they can shape board composition and long-term priorities. Generic and branded agrochemical suppliers compete closely on cost, formulation and distribution reach, so ownership moves at a major producer are followed across the industry.</p>
<p class="mkn-source">Source: <a href="https://www.fmc.com/en/articles/fmc-corporation-and-tessenderlo-group-complete-minority-equity-investment" target="_blank" rel="noopener nofollow">official release on fmc.com</a>. Summary and context written by Market Krystal.</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-corporation-welcomes-tessenderlo-group-as-20-minority-shareholder/">FMC Corporation Welcomes Tessenderlo Group as 20% Minority Shareholder</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2538</post-id>	</item>
		<item>
		<title>FMC Corporation Agrees to Sell India Commercial Business to Crystal Crop</title>
		<link>https://www.marketkrystal.com/chemical-news/fmc-corporation-agrees-to-sell-india-commercial-business-to-crystal-crop/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate>
				<guid isPermaLink="false">https://www.marketkrystal.com/chemical-news/fmc-corporation-agrees-to-sell-india-commercial-business-to-crystal-crop/</guid>

					<description><![CDATA[<p>FMC Corporation has signed a definitive agreement to sell FMC India Private Limited to Crystal Crop Protection Limited for $252 million, subject to customary adjustments for cash, debt and working…</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-corporation-agrees-to-sell-india-commercial-business-to-crystal-crop/">FMC Corporation Agrees to Sell India Commercial Business to Crystal Crop</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="mkn-brief">FMC Corporation has signed a definitive agreement to sell FMC India Private Limited to Crystal Crop Protection Limited for $252 million, subject to customary adjustments for cash, debt and working capital. Crystal will acquire FMC India&#039;s crop protection commercial operations, a license to FMC&#039;s brands sold in India, and preferred access to FMC&#039;s India active ingredient pipeline. FMC will keep receiving cash from the India business until closing, expected by year-end 2026, subject to regulatory approval, and will use all proceeds to reduce debt.</p>
<div class="mkn-why"><strong>Why it matters</strong></p>
<p>FMC will supply active ingredients and formulated products to Crystal under a preferred supply agreement, while FMC keeps global R&amp;D and manufacturing operations in India, shaping Indian crop protection supply and competition.</p>
</div>
<h2>Key facts</h2>
<table class="mkn-facts">
<tbody>
<tr>
<th scope="row">Companies</th>
<td>FMC Corporation, FMC India Private Limited, Crystal Crop Protection Limited, BofA Securities, Davis Polk &amp; Wardwell LLP, Khaitan &amp; Co, EY, Shardul Amarchand Mangaldas &amp; Co</td>
</tr>
<tr>
<th scope="row">Chemicals</th>
<td>crop protection active ingredients, formulated crop protection products</td>
</tr>
<tr>
<th scope="row">Investment</th>
<td>$252 million USD consideration, subject to customary adjustments for cash, debt and working capital</td>
</tr>
<tr>
<th scope="row">Location</th>
<td>India</td>
</tr>
<tr>
<th scope="row">Timing</th>
<td>May 7, 2026, July 2025, year-end 2026</td>
</tr>
<tr>
<th scope="row">Partners</th>
<td>Crystal Crop Protection Limited</td>
</tr>
<tr>
<th scope="row">End uses</th>
<td>crop protection for Indian farmers</td>
</tr>
</tbody>
</table>
<h2>Market context</h2>
<p>Crop protection chemicals, including herbicides, insecticides and fungicides, protect crops from weeds, pests and diseases, and their demand is driven mainly by agriculture, especially grain, oilseed, fruit and vegetable production. In India, where farm inputs are sold through a large network of regional distributors and retailers, the market is shaped by monsoon patterns, crop prices, generic competition and pricing pressure from low-cost producers. Divestitures like this one change who controls commercial access to brands and products in a market, while the seller often keeps upstream roles such as manufacturing and research. Supply arrangements tying a seller&#039;s active ingredients to a buyer&#039;s formulation and distribution network can stabilize volumes for both sides, though they also concentrate sales channels. For chemical buyers and investors, such moves are worth tracking because they can alter competitive dynamics, distribution strength and the flow of active ingredients into a major agricultural market.</p>
<p class="mkn-source">Source: <a href="https://www.fmc.com/en/articles/fmc-corporation-announces-agreement-divest-india-commercial-business-crystal-crop" target="_blank" rel="noopener nofollow">official release on fmc.com</a>. Summary and context written by Market Krystal.</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-corporation-agrees-to-sell-india-commercial-business-to-crystal-crop/">FMC Corporation Agrees to Sell India Commercial Business to Crystal Crop</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2534</post-id>	</item>
		<item>
		<title>FMC Reports Q1 2026 Results Above Guidance, Reaffirms Full-Year Outlook</title>
		<link>https://www.marketkrystal.com/chemical-news/fmc-reports-q1-2026-results-above-guidance-reaffirms-full-year-outlook/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate>
				<guid isPermaLink="false">https://www.marketkrystal.com/chemical-news/company-continues-to-advance-operational-priorities-and-explore-strategic-options-in-parallel/</guid>

					<description><![CDATA[<p>FMC Corporation reported first quarter 2026 revenue of $759 million, down 4 percent year over year, with Adjusted EBITDA of $72 million, down 40 percent, as lower pricing and tariff-driven…</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-reports-q1-2026-results-above-guidance-reaffirms-full-year-outlook/">FMC Reports Q1 2026 Results Above Guidance, Reaffirms Full-Year Outlook</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="mkn-brief">FMC Corporation reported first quarter 2026 revenue of $759 million, down 4 percent year over year, with Adjusted EBITDA of $72 million, down 40 percent, as lower pricing and tariff-driven costs weighed on results. Price fell 6 percent, reflecting lower pricing to diamide partners, Rynaxypyr pricing actions and a competitive legacy core market in Latin America, while volume rose 2 percent and new active ingredient sales doubled. The company reaffirmed 2026 revenue excluding India of $3.60 billion to $3.80 billion and Adjusted EBITDA of $670 million to $730 million, and is pursuing a debt reduction of about $1 billion.</p>
<div class="mkn-why"><strong>Why it matters</strong></p>
<p>Lower Rynaxypyr pricing and competitive pressure in legacy core products, alongside growth in new actives like Isoflex, fluindapyr and Dodhylex, signal a shift in crop protection supply economics and pricing across diamide and core portfolios.</p>
</div>
<h2>Key facts</h2>
<table class="mkn-facts">
<tbody>
<tr>
<th scope="row">Companies</th>
<td>FMC Corporation</td>
</tr>
<tr>
<th scope="row">Chemicals</th>
<td>Rynaxypyr, Isoflex, fluindapyr, Dodhylex</td>
</tr>
<tr>
<th scope="row">Investment</th>
<td>Targeted debt reduction of approximately $1 billion</td>
</tr>
<tr>
<th scope="row">Timing</th>
<td>First quarter 2026, April 29, 2026, First quarter 2025, February 2026, 2026 full year, Second quarter 2026, Second half 2026</td>
</tr>
<tr>
<th scope="row">Partners</th>
<td>Diamide partners</td>
</tr>
<tr>
<th scope="row">End uses</th>
<td>Agricultural crop protection, Growers and crop advisers</td>
</tr>
</tbody>
</table>
<h2>Market context</h2>
<p>FMC is an agricultural chemicals company, and its products are crop protection active ingredients used by growers and crop advisers to control insects, fungi and other pests in row crops, fruits, vegetables and specialty crops. Demand is driven by farm incomes, planting areas, pest pressure and the availability of generic alternatives. Diamide insecticides such as Rynaxypyr, a ryanodine receptor modulator, have been widely adopted, so pricing moves in that class tend to ripple through the sector as generic producers compete for share. Newer active ingredients typically carry premium pricing during their early commercial years, which makes growth in new actives important for margin mix. Lower average selling prices combined with tariff-related input costs compress profitability even when volumes rise, a pattern common across agrochemical makers. Buyers of crop protection intermediates and formulators should watch whether pricing pressure in legacy diamides persists and whether competitors respond with their own price adjustments.</p>
<p class="mkn-source">Source: <a href="https://www.fmc.com/en/articles/fmc-corporation-reports-first-quarter-2026-results-above-guidance-adjusted-ebitda-above" target="_blank" rel="noopener nofollow">official release on fmc.com</a>. Summary and context written by Market Krystal.</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-reports-q1-2026-results-above-guidance-reaffirms-full-year-outlook/">FMC Reports Q1 2026 Results Above Guidance, Reaffirms Full-Year Outlook</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2467</post-id>	</item>
		<item>
		<title>FMC Corporation Agrees to $400 Million Equity Investment from Tessenderlo Group</title>
		<link>https://www.marketkrystal.com/chemical-news/fmc-corporation-agrees-to-400-million-equity-investment-from-tessenderlo-group/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate>
				<guid isPermaLink="false">https://www.marketkrystal.com/chemical-news/fmc-corporation-agrees-to-400-million-equity-investment-from-tessenderlo-group/</guid>

					<description><![CDATA[<p>FMC Corporation agreed to a definitive deal under which Tessenderlo Group will make a strategic minority equity investment of about $400 million at $13.30 per share, giving Tessenderlo roughly 20.0%…</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-corporation-agrees-to-400-million-equity-investment-from-tessenderlo-group/">FMC Corporation Agrees to $400 Million Equity Investment from Tessenderlo Group</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="mkn-brief">FMC Corporation agreed to a definitive deal under which Tessenderlo Group will make a strategic minority equity investment of about $400 million at $13.30 per share, giving Tessenderlo roughly 20.0% of FMC&#039;s outstanding common stock upon completion. FMC intends to use the proceeds to pay down debt and reach its approximately $1 billion debt paydown target, concluding its strategic options review announced in February 2026. Closing is subject to customary conditions, including regulatory approvals. BofA Securities and Goldman Sachs are financial advisors to FMC.</p>
<div class="mkn-why"><strong>Why it matters</strong></p>
<p>FMC&#039;s deleveraging and continued pipeline investment in new proprietary crop protection molecules could alter competitive dynamics in herbicides, insecticides and fungicides, with cornerstone investor Tessenderlo holding about 20%.</p>
</div>
<h2>Key facts</h2>
<table class="mkn-facts">
<tbody>
<tr>
<th scope="row">Companies</th>
<td>FMC Corporation, Tessenderlo Group</td>
</tr>
<tr>
<th scope="row">Investment</th>
<td>Approximately $400 million USD minority equity investment at $13.30 per share; Tessenderlo Group to own approximately 20.0% of FMC common stock</td>
</tr>
<tr>
<th scope="row">Timing</th>
<td>June 30, 2026, February 2026</td>
</tr>
<tr>
<th scope="row">Partners</th>
<td>Tessenderlo Group, BofA Securities, Goldman Sachs &amp; Co. LLC, Davis Polk &amp; Wardwell LLP, Stibbe BV/SRL, Sullivan &amp; Cromwell LLP</td>
</tr>
<tr>
<th scope="row">End uses</th>
<td>agricultural sciences, crop protection</td>
</tr>
</tbody>
</table>
<h2>Market context</h2>
<p>FMC is a crop protection company whose products include herbicides, insecticides and fungicides used to protect corn, soybeans, cereals, fruit and vegetables from weeds, insects and disease. Demand for these products follows planted acreage, crop prices, farm incomes and pest pressure, so the agricultural cycle is the main driver for the sector. Agrochemical makers also depend on a steady pipeline of new active ingredients, since patent expiries bring generic competition that erodes margins on older molecules. Companies that cut debt can often keep funding research and development and maintain supply of established products, while a large shareholder can influence strategy and capital allocation. Generic producers in China and India have been expanding supply of off-patent crop chemicals, so pricing pressure on mature products remains a key consideration for buyers and investors tracking the sector.</p>
<p class="mkn-source">Source: <a href="https://www.fmc.com/en/articles/fmc-corporation-reaches-agreement-400-million-minority-equity-investment-tessenderlo-group" target="_blank" rel="noopener nofollow">official release on fmc.com</a>. Summary and context written by Market Krystal.</p>
<p>The post <a href="https://www.marketkrystal.com/chemical-news/fmc-corporation-agrees-to-400-million-equity-investment-from-tessenderlo-group/">FMC Corporation Agrees to $400 Million Equity Investment from Tessenderlo Group</a> appeared first on <a href="https://www.marketkrystal.com">Market Krystal</a>.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2536</post-id>	</item>
	</channel>
</rss>
